We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Brachytherapy Device Provides Breast-Conserving Treatment

By HospiMedica staff writers
Posted on 08 Nov 2006
Print article
A new device provides a multi-catheter, single-entry approach to breast brachytherapy as part of breast-conserving cancer treatment.

The SAVI applicator, developed by BioLucent, Inc. (Aliso Viejo, CA, USA), will be presented at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO), November 5-9, 2006, in Philadelphia (PA,USA). The SAVI applicator is for use in accelerated partial breast irradiation (APBI) after lumpectomy. The applicator is a hybrid of two earlier APBI approaches, combining the tissue-sparing dosimetry of interstitial brachytherapy with the single-entry ease of intracavitary (balloon) brachytherapy.

The device's ability to deliver a precisely targeted dose of radiation is designed to give more flexibility in treatment planning to the radiation oncologist and physicist. APBI was developed as an alternative to whole-breast irradiation. Both whole-breast irradiation and APBI are used after breast-conserving surgery to decrease the risk of ipsilateral breast tumor recurrence. The course of daily treatment for whole-breast irradiation is five to seven weeks.

With APBI, treatment is completed in five days. Other potential benefits of APBI include improved access to breast-conserving therapy, lower risk of injury to healthy tissue, and a faster transition to chemotherapy. "BioLucent developed SAVI in part as a response to research showing that the inconvenience of whole-breast irradiation causes many women to forgo breast-conserving therapy and to be treated with mastectomy,” said Jill Anderson, BioLucent's president.

SAVI may provide a better alternative for these women, Ms. Anderson said. "There is no reason for women to avoid risk-reducing radiation therapy. We believe SAVI may give them another option, by providing a breast-conserving approach that minimizes disruption to their work and family life.”

The SAVI device includes an expandable bundle of catheters that surround a central lumen. The applicator is placed by the clinician into the lumpectomy cavity through a small incision. The clinician expands the catheter bundle by turning a mechanism from outside the breast. The catheters expand to form an ellipsoidal shape inside the cavity. Delivery of radiation through the device's individual catheters allows the doctors better control of the radiation dose.



Related Links:
BioLucent
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
New
Cementless Partial Knee
Oxford

Print article

Channels

Surgical Techniques

view channel
Image: The innovative endoscope precisely identifies and removes tumors with laser light (Photo courtesy of Science Advances 10, eado9721 (2024). DOI: 10.1126/sciadv.ado9721)

Innovative Endoscope Precisely Identifies and Selectively Removes Tumor Tissue in Real Time

One of the most significant challenges in cancer surgery is completely removing a tumor without harming surrounding healthy tissue. Current techniques, such as intraoperative tissue sampling, only provide... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.